Center effects are differences in outcome among treatment centers that cannot be explained by identifiable differences in patients treated or specific treatments applied and are presumed to result from differences in the ways health care is delivered. This paper will briefly review studies of association between treatment center factors and clinical outcomes in general medicine and surgery and look more closely at studies involving hematopoietic stem cell transplantation. We will also attempt to identify conceptual domains to study further the processes and mechanisms that may be associated with better outcomes.
ter effects; transplant outcomes High-dose chemotherapy with or without radiotherapy followed by hematopoietic stem cell support is widely used to treat diverse malignant and nonmalignant diseases. [1] [2] [3] [4] Data reported to the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry (ABMTR) indicate that about 20 000 hematopoietic stem cell transplants were performed in the United States in 1999. 5 Transplants may use hematopoietic stem cells from related or unrelated donors (URDs) (allotransplants) or from patients themselves (autotransplants). Hematopoietic stem cells may be collected from bone marrow, peripheral blood or umbilical cord blood. 6 Pretransplant conditioning regimens are heterogeneous, even when considering transplants for a single indication, as are procedures and drugs used for stem cell collection, graft-versus-host disease (GVHD) prophylaxis and post-transplant support. [7] [8] [9] Hematopoietic stem cell transplantation (HSCT) carries high risks of early morbidity and mortality. These include infection, bleeding, mucositis, graft failure, acute or chronic GVHD, and major organ toxicity (renal failure, hepatic veno-occlusive disease, pulmonary problems). Transplantrelated mortality (TRM) ranges from 3% to over 50%, depending on underlying disease, patient age and performance status and type of transplant. Patients at high risk of post-transplant complications can be identified by these and other clinical features. 4, 10 Most transplant-related deaths occur in the first year post-transplant.
While predictors of (HSCT) outcomes, particularly survival, are traditionally evaluated using clinical parameters related to the patient (age, sex, performance score, etc), the disease (stage of disease, extent of involvement, etc), or the transplant procedure (type of graft, type of donor, pretransplant intervention, etc), biological paradigms may not completely explain outcome variations. Although the biology of the disease process and efficacy of available therapies largely determine clinical outcomes in any disease entity, outcomes may vary among patients with similar disease biology and treatment. Examining transplantation outcomes from a more integrative biopsychosocial approach entails understanding and dissecting how the organization and delivery of health care affects clinical outcomes. The assumption that health care system factors, specifically medical organization, setting and culture, may affect HSCT outcome is the basis for studying center effect.
What is center effect?
It is generally assumed that there are optimal health care delivery factors that result in superior clinical outcomes. Center effects are differences in outcome among treatment centers that cannot be explained by identifiable differences in patients treated or specific treatments applied and are presumed to result from differences in the ways health care is delivered, for example, training and experience of personnel, availability of resources and characteristics of center organization. Individual center characteristics may not be equally important (or important at all) for optimal patient outcomes. Center characteristics associated with clinical outcomes may also vary with the political structure of the health systems at any given geographic location (eg United States vs Canada). This paper will briefly review studies of association between treatment center factors and clinical outcomes in general medicine and surgery and look more closely at studies done in the HSCT setting. We will also attempt to identify conceptual domains to study further processes and mechanisms associated with better outcomes.
Center effects and outcomes in medicine and surgery

Procedure volume studies
The treatment center characteristic that has been the focus of many studies in medical and surgical intervention is procedure volume. Procedure volume is defined as the number of procedures done annually by a specific group of physicians or hospitals. It is an appealing measure to many investigators because it is readily available and easily quantified. More detailed evaluation of health care factors involved in delivery of care is highly labor intensive, partly due to high rates of variability and difficulty in quantifying factors such as physician experience and training.
The Institute of Medicine Committee on Quality of Health Care in America examined 88 studies on the volume-outcome relation in procedures such as coronary artery bypass graft (CABG) surgery, pediatric cardiac surgery, carotid endarterectomy, abdominal aortic aneurysm repair, cancer surgery, percutaneous transcoronary angioplasty (PTCA), treatment for acute myocardial infarction, and treatment for acquired immune deficiency syndrome. They found a positive volume-outcome relation in 79% of the hospital volume and 77% of the physician volume studies, that is, better outcome with more procedures per hospital/physician. None of the studies revealed a negative effect of volume on outcome. 11 Lack of association between volume and outcome was found in surgical procedures that were less complicated and where clinical case mix (patient selection, disease stage, prior treatment applied, etc) was great.
Most studies of center effect in cancer treatment also focus on procedure volume. Hillner et al 12 reviewed extensively the health services literature looking at evidence of provider, facilities or delivery system characteristics affecting the quality of cancer care, meaning improved clinical outcomes. The review found large variations in the relation between volume and outcomes. Evidence for improved short-and long-term survival with higher procedure volume was found largely in surgical interventions for cancer; however, not all surgical procedures showed a volume-outcome relation. Consistent volumeoutcome relations were seen in high-risk surgical procedures such as gastrectomy, pancreatectomy, esophagectomy, lung lobectomy and hepatectomy. Conflicting results were seen with low-risk surgery for common cancers such as cancer of the breast, colon, prostate, and ovary. There was modest support for an association between volume and long-term outcome of chemotherapy. Although practice variation is assumed to be wide for chemotherapeutic interventions in cancer, few studies address center effects in this area.
Health provider studies
One study found that patients receiving care in medical intensive care units (ICUs) with high ICU staff workload were at higher risk for mortality (odds ratio 3.1; 95% confidence interval of 1.9-5.0) than those in low staff workload units. Parameters used to quantify staff workload included: peak occupancy (highest occupancy per shift during the patients stay), average nursing requirement per occupied bed per shift and ratio of occupied to appropriately staffed beds. 13 Another study by Provonost et al 14 among ICU patients who underwent abdominal aortic surgery has found that a nurse-patient ratio of more than 1 : 2, not having a full time ICU medical director, having less than 50% of ICU attendings certified in critical care, and not having daily rounds by an ICU physician were associated with higher in-hospital mortality. A more recent study by Needleman et al 15 further quantified the association between nurse staffing levels, defined as the number of hours per patient-day that nursing staff devoted to patients, with in-hospital outcomes. They found that among medical patients, a higher absolute number of hours of care per day was associated with shorter hospital stays, lower rates of urinary tract infection, lower rates of upper gastrointestinal bleeding, lower rates of pneumonia, and lower rates of cardiac arrest. Staffing levels were, however, not found to be associated with fewer in-hospital deaths. Similarly, studies on physician providers found lower clinician workload and more procedure experience were associated with decreased mortality in patients with breast cancer treated with surgery for curative intent. 16 Sainsbury et al 17 found that higher consultant caseloads, defined as treating at least 30 new breast cancer patients per year, were associated with a lower risk of death (OR 0.8; 0.7-0.9) when compared to workloads of less than 10. Meagher reviewed 13 studies looking at the association between surgeon caseload and postoperative mortality. Though the studies do not have a consensus as to the minimal surgical caseload for superior outcomes, all 13 studies found lower operative mortality with high procedure volume.
Affiliation of hospitals with teaching institutions is also associated with superior survival. Using Medicare patients with a diagnosis of acute myocardial infarction from 4361 hospitals, Allison et al 18 found a gradient of increasing mortality from major teaching to minor teaching to nonteaching hospitals. Patients treated in major teaching institutions have decreased mortality compared to those in nonteaching hospitals (OR 0.8; 0.7-0.8). Table 1 lists the center effect conceptual domains generally examined in the general medicine and surgery literature. Table 1 Center Effect conceptual domains studied in general medicine and surgery associated with clinical outcomes Procedure volume Health provider experience * Nurse time devoted to actual patient care * Nurse : patient ratio * Physician experience (caseload, specialization), caring activity and certification * Physician trainee involvement Medical center affiliation to teaching school
Center effect and outcomes in stem cell transplantation
In the HSCT setting, there appears to be an association between volume and survival. Horowitz et al 19 reported in 1992 that, among patients receiving HLA-identical sibling transplantation for acute and chronic leukemias in early stages, TRM and treatment failure were higher in transplant centers doing five or fewer allogeneic transplants per year after adjusting for pertinent patient-, disease-and transplant-related characteristics. The study found patients transplanted at centers performing an average of five or fewer patients per year had a 1.5-fold greater risk of experiencing TRM and have a 1.4-fold greater risk of treatment-failure than those at centers performing more than five transplants per year. These relative risks equate to a 10% difference in treatment-related deaths and an 8% difference in treatment-failure at 2 years post-transplant. In the URD HSCT setting, Hows et al 20 reported in 1993, that small-sized centers (o2 URD procedures per year) had inferior survival than medium to large-sized centers. A report by Matsuo et al 21 , evaluating HSCT patients from 121 transplant centers in Japan, also showed a correlation between volume and survival. Volume was defined as the cumulative number of patients transplanted in a 7-year period. Low-volume centers were defined as centers performing fewer than 25 transplants during the study period. Adjusting for pertinent clinical variables, including donor source and HLA-matching status, patients receiving allogeneic transplants for leukemia at low-volume centers had a 1.3-fold higher risk of death and treatment-failure than those at high volume centers (X76 cumulative cases in study period). The above results, however, were not found in patients receiving allogeneic transplants for lymphoma, myelodysplastic syndrome and severe aplastic anemia, although patient numbers were smaller than in the leukemia cohort. Frassoni et al 22 reported that outcomes of HLA-identical sibling transplants for early stage acute leukemia varied across European centers. The study found age at transplant, interval from diagnosis to first complete remission and T-cell depletion of donor marrow were predictive of TRM and treatment-failure. However, the degree to which these clinical factors affected the outcomes studied differed according to the volume of transplants performed in each center. Treatment-related mortality was significantly lower in high volume centers, defined as centers with at least 352 cumulative transplants during the 8-year study period, with a relative risk of 0.5. Similarly, high volume centers were found to have a significantly lower risk of treatment failure with a relative risk of 0.7. Additionally, the study found higher TRM in centers that started doing transplants after 1980 than in centers who started earlier. An abstract presented at the 2000 American Society of Hematology meeting by Apperley et al 23 showed that center size (number of allogeneic transplants per year) and center experience (number of years the transplant center had operated) correlated with overall survival and TRM after bone marrow transplantation for CML.
Studies examining center effects in the HSCT setting are summarized in Table 2 . The studies suggest the following: (1) although a threshold for what is considered 'high procedure volume' has not been consistently defined, the relation between higher volume and superior clinical outcomes is replicable; (2) outcomes associated with center effect (mainly procedure volume) include TRM, treatmentfailure, and survival, but not relapse; (3) data for Table 2 Studies primarily looking at the center effects in hematopoietic stem cell transplantation setting autologous transplantation are lacking; (4) associations between center characteristics and outcome may vary depending on patient and disease selection; and (5) center effect studies have largely been focused on procedure volume with none of the studies evaluating the broad range of other characteristics that might potentially affect outcomes and that also might reasonably be expected to differ between small and large centers.
Why center effect requires further study HSCT centers are increasingly driven to provide quality patient care. Attempts to improve and ensure quality care, at least in the United States, include in-house quality improvement projects/initiatives, requirements for continuous process improvement by organizations such as the National Marrow Donor Program and participation in voluntary accreditation programs such as the Foundation for the Accreditation of Cellular Therapy (FACT). Some international agencies providing accreditation stipulate minimum numbers of transplants per year as an indicator of center quality. 23 Based upon current evidence regarding procedure volume, it is not clear that any specific minimum number is justifiable. Restricting procedures to large centers may compromise patient access to HSCT in geographic areas where no large centers exist. Although existing data support the idea that the volume of procedures influences clinical outcome of many medical and surgical interventions for cancer, [24] [25] [26] it is unknown whether procedure volume directly affects outcome (eg by increasing experience of personnel) or is a surrogate or summary measure for other factors that are associated with both improved outcomes and larger volumes. This distinction is important, since if volume per se is the important parameter, one can make a strong case for restricting procedures to large centers. If, on the other hand, volume is a surrogate for other factors that are more common in large vs small centers, but which could be introduced into small centers, the appropriate course of action would be to set standards for these factors to be adhered to by large and small centers. For instance, if studies substantiate that clinician and staff workload affect survival in the HSCT setting, then it may be possible for small centers to optimize other operational features (for instance, staffing) to ensure good outcomes, rather than attempt to increase procedure volume.
Future directions
The body of knowledge regarding center effects in the HSCT setting is sparse. The IBMTR and ABMTR recently obtained funding from the Agency for Healthcare Research and Quality to study this area in the United States. We proposed to look at the following center-specific domains after reviewing the medical literature and consulting experts in the transplant field: (1) Physician and health provider characteristics: these reflect staff workload and experience in HSCT. The workload assessment focuses on the reasonable belief that supportive care rendered by a health care provider is best given when the ratio of health care provider to patient is at a maximum, especially in the demanding post-transplant setting; (2) Transplant unit resources: This refers to specific services or resources that reflect a transplant center's sophistication or ability to provide services; and (3) Medical center organization: This denotes the structure, capacity, geography, and standards of the transplant centers and the institutions in which they operate. It is hypothesized that centers with high standards, as reflected by their recognition by regulatory bodies, and centers with tertiary levels of care will have better clinical outcomes. Table 3 lists the areas that might directly or indirectly influence clinical outcome in the HSCT setting and which will be the focus of these analyses.
Another issue worth comment is the selection of outcome to be evaluated. Treatment-related mortality and overall survival (death from any cause) are suitable based on previous studies. The choice of timing for these outcomes, however, may not be easy. Individual centers may have different follow-up programs (both immediate post-transplant and long-term) that could potentially affect the degree to which center factors may influence outcome. The 100-day time period is probably the most appropriate time period in which to assess center effects point since patients are most likely cared for by their transplant physicians before being referred to local physicians/centers for longterm follow-up. Outcomes at 1 year may still have some use, but may only be relevant for centers with long-term Table 3 Proposed conceptual domains of treatment center factors associated with clinical outcome The goal of these studies is to describe the variations in how health care is delivered in the HSCT setting in a variety of conceptual domains (Table 3) and to understand how these variations affect HSCT outcomes. Such information should help all centers improve their quality of care and, in so doing, improve the outcome of HSCT recipients.
